NCR3LG1 and glioma: Since its identification in clinical lymphoma samples, liquid cancer cell lines, including B lymphoma, T lymphoma, and myeloid leukemia, and solid cancer cell lines, including melanoma, colon carcinoma, and cervical carcinoma [7], several studies have confirmed the expression of B7-H6 in various types of liquid and solid cancer samples and cell lines, including cervical cancer, hepatocellular carcinoma, glioma, non-Hodgkin lymphoma, T-cell lymphoblastic lymphoma, and diffuse large B-cell lymphoma.